Comparative cytotoxicity, DNA synthesis inhibition and drug incorporation of eight anthracyclines in a model of doxorubicin-sensitive and -resistant rat glioblastoma cells
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 38 (1), 167-172
- https://doi.org/10.1016/0006-2952(89)90164-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of actionBiochemistry, 1987
- DNA topoisomerase II: A primer on the enzyme and its unique role as a multidrug target in cancer chemotherapyPharmacology & Therapeutics, 1987
- Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)Cancer Chemotherapy and Pharmacology, 1986
- Cellular Pharmacology of Doxorubicin in Sensitive and Resistant Rat Glioblastoma Cells in CultureOncology, 1986
- Tumour cell resistance to anthracyclines ? A reviewCancer Chemotherapy and Pharmacology, 1985
- Phase I trial of esorubicin (4'deoxydoxorubicin).Journal of Clinical Oncology, 1984
- 4′-epi-doxorubicin, a new analogue of doxorubicin: a preliminary overview of preclinical and clinical dataCancer Treatment Reviews, 1983
- Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin.The Journal of Antibiotics, 1983
- Adriamycin—A ReviewJNCI Journal of the National Cancer Institute, 1975
- Differentiated Rat Glial Cell Strain in Tissue CultureScience, 1968